Found: 5
Select item for more details and to access through your institution.
Chronic signs of memory B cell activation in patients with Behçet's disease are partially restored by anti-tumour necrosis factor treatment.
- Published in:
- Rheumatology, 2017, v. 56, n. 1, p. 134, doi. 10.1093/rheumatology/kew366
- By:
- Publication type:
- Article
Leukocyte toll-like receptor expression in pathergy positive and negative Behçet's disease patients.
- Published in:
- Rheumatology, 2020, v. 59, n. 12, p. 3971, doi. 10.1093/rheumatology/keaa251
- By:
- Publication type:
- Article
A pilot study into bosentan (Tracleer<sup>®</sup>) as an immunomodulating agent in patients with Behçet’s disease.
- Published in:
- Asian Pacific Journal of Allergy & Immunology, 2022, v. 40, n. 4, p. 435, doi. 10.12932/ap-160919-0648
- By:
- Publication type:
- Article
Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01192
- By:
- Publication type:
- Article
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0160103
- By:
- Publication type:
- Article